72 - Hot Topics in PrEP

Speaker(s)

• 

  Oni Blackstock, MD, MHS

  Attending Physician
  Harlem Hospital
  New York, New York

  Disclosure: Gilead Sciences : Consultant (Status: Ongoing)
• 

  Diana Brainard, MD

  SVP, Therapeutic Area Head, Virology
  Clinical Research - HIV
  Gilead Sciences Inc.
  Foster City, CA

  Disclosure: Gilead Sciences : Employee
• AH

  Andrew Hill

  Liverpool University

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

No CME/MOC/CPE credits available for this session

Learning Objectives:

• safety of TAF vs TDF-FTC for PrEP what does the evidence tell us?
• options for cisgender women
• shared decision making with patients about PrEP options

Presentations:

• 12:30pm – 1:45pm EDT

  Our Path Forward: HIV Prevention in Women
  Diana M. Brainard, MD – Gilead Sciences Inc.
• 12:30pm – 1:45pm EDT

  Safety of TAF vs TDF-FTC for Prep What Does the Evidence Tell Us?
  Andrew Hill – Liverpool University
• 12:30pm – 1:45pm EDT

  Shared Decision Making with Patients About Prep Options
  Oni Blackstock, MD, MHS – Harlem Hospital